These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 16573780)
21. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054 [TBL] [Abstract][Full Text] [Related]
22. An association study of inflammatory cytokine gene polymorphisms in Fabry disease. Safyan R; Whybra C; Beck M; Elstein D; Altarescu G Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161 [TBL] [Abstract][Full Text] [Related]
23. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases. Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906 [TBL] [Abstract][Full Text] [Related]
24. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India. Mittal RD; Manchanda PK; Bid HK; Ghoshal UC J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649 [TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678 [TBL] [Abstract][Full Text] [Related]
27. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population. Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269 [TBL] [Abstract][Full Text] [Related]
28. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129 [TBL] [Abstract][Full Text] [Related]
29. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease. Palmieri O; Latiano A; Salvatori E; Valvano MR; Bossa F; Latiano T; Corritore G; di Mauro L; Andriulli A; Annesec V Am J Gastroenterol; 2010 Jul; 105(7):1586-94. PubMed ID: 20125127 [TBL] [Abstract][Full Text] [Related]
31. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Márquez A; Orozco G; Martínez A; Palomino-Morales R; Fernández-Arquero M; Mendoza JL; Taxonera C; Díaz-Rubio M; Gómez-García M; Nieto A; López-Nevot MA; de la Concha EG; Martín J; Urcelay E Am J Gastroenterol; 2009 Aug; 104(8):1968-75. PubMed ID: 19471255 [TBL] [Abstract][Full Text] [Related]
32. Heat shock protein gene 70-2 polymorphism is differentially associated with the clinical phenotypes of ulcerative colitis and Crohn's disease. Nam SY; Kim N; Kim JS; Lim SH; Jung HC; Song IS J Gastroenterol Hepatol; 2007 Jul; 22(7):1032-8. PubMed ID: 17532782 [TBL] [Abstract][Full Text] [Related]
33. Is interleukin-6 important in inflammatory bowel disease? Koss K; Satsangi J; Welsh KI; Jewell DP Genes Immun; 2000 Feb; 1(3):207-12. PubMed ID: 11196713 [TBL] [Abstract][Full Text] [Related]
34. Contribution of IBD5 locus to clinical features of IBD patients. Latiano A; Palmieri O; Valvano RM; D'Incà R; Vecchi M; Ferraris A; Sturniolo GC; Spina L; Lombardi G; Dallapiccola B; Andriulli A; Devoto M; Annese V Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837 [TBL] [Abstract][Full Text] [Related]
35. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs. López P; Gómez J; Mozo L; Gutiérrez C; Suárez A Arthritis Res Ther; 2006; 8(2):R42. PubMed ID: 16507146 [TBL] [Abstract][Full Text] [Related]
36. The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996 [TBL] [Abstract][Full Text] [Related]
37. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. Van Limbergen J; Nimmo ER; Russell RK; Drummond HE; Smith L; Anderson NH; Davies G; Arnott ID; Wilson DC; Satsangi J Hum Mol Genet; 2007 Sep; 16(18):2175-86. PubMed ID: 17613538 [TBL] [Abstract][Full Text] [Related]
38. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease]. Waterman M; Karban A; Nesher S; Weiss B; Shamir R; Eliakim R Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946 [TBL] [Abstract][Full Text] [Related]
39. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306 [TBL] [Abstract][Full Text] [Related]
40. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Khazen D; Jendoubi-Ayed S; Aleya WB; Sfar I; Mouelhi L; Matri S; Najjar T; Filali A; Gorgi Y; Abdallah TB; Ayed K Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):167-75. PubMed ID: 19212205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]